Latigo Biotherapeutics Appoints Todd N. Smith President and CEO
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
11:46:44 AM UTC
SquawkNews
Todd N. Smith, a seasoned executive with deep experience commercializing pain therapies, appointed as president and chief executive officer to lead Latigo through planned late-stage development and commercialization of the Company’s pipeline of non-opioid pain treatment programsNima Farzan will rem…
11:46:54 AM UTC
SquawkNews
Latigo Biotherapeutics, Inc. appointed Todd N. Smith president and CEO, effective immediately. Nima Farzan will remain a strategic advisor through 2027.Material DetailsContext by AI AnalystThis is a leadership transition at a clinical-stage company preparing for planned late-stage development, not…
11:47:08 AM UTC
SquawkNews
Latigo Biotherapeutics Names Todd N. Smith President and CEO, Succeeding Nima Farzan Latigo Biot
11:48:17 AM UTC
SquawkNews
Todd N. Smith was appointed president and CEO effective immediately as Latigo shifts toward late-sta